For patients

Our reason to exist is to improve the quality of life of patients with vision loss due to large gene related inherited retinal diseases (IRDs) and to be able to help patients outside the ophthalmology space in the future with our technology for large-gene delivery.

Our two ocular lead programs aim to restore visual function and halt disease progression in Usher 1B and Stargardt’s patients.